Contact
searchSearch
HMP Global
Login

Non-Small Cell Lung Cancer Videos

Sawsan Rashdan, MD
Videos
Future Directions in NSCLC Care: Navigating Pathways, Costs, and Cutting-Edge Therapies
11/14/2024
Dr. Sawsan Rashdan, an associate professor at UT Southwestern Medical Center specializing in lung cancer, discusses the transformative impact of targeted therapies and immunotherapies on NSCLC treatment.
Dr. Sawsan Rashdan, an associate professor at UT Southwestern Medical Center specializing in lung cancer, discusses the transformative impact of targeted therapies and immunotherapies on NSCLC treatment.
Dr. Sawsan Rashdan, an associate...
11/14/2024
Journal of Clinical Pathways
Federico Cappuzzo, MD, National Cancer Institute Regina Elena
Videos
The Impact of Subcutaneous Formulation of Atezolizumab on Treatment for Patients with Non-Small Cell Lung Cancer
10/17/2024
Federico Cappuzzo, MD, discusses the benefits of the subcutaneous formulation of atezolizumab compared with the intravenous route.
Federico Cappuzzo, MD, discusses the benefits of the subcutaneous formulation of atezolizumab compared with the intravenous route.
Federico Cappuzzo, MD, discusses...
10/17/2024
Oncology
Yating Wang, MD
Videos
Survival Trends Among Patients With Metastatic NSCLC Before and After the Approval of Immunotherapy in the US
09/27/2024
Yating Wang, MD, shares the findings and future implications of her study on survival trends among patients with metastatic non–small cell lung cancer (NSCLC) before and after the approval of immunotherapy in the US.
Yating Wang, MD, shares the findings and future implications of her study on survival trends among patients with metastatic non–small cell lung cancer (NSCLC) before and after the approval of immunotherapy in the US.
Yating Wang, MD, shares the...
09/27/2024
Journal of Clinical Pathways
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
Journal of Clinical Pathways
Luke Pike, MD
Videos
Evaluating Stereotactic Radio Surgery Plus TKI Vs TKI Alone Among Patients With Brain Metastases from EGFR- and ALK-Altered NSCLC (Part II)
09/18/2024
Luke Pike, MD, shares key takeaways from the TURBO-Non–Small Cell Lung Cancer study and highlights promising studies on the horizon for EGFR mutant NSCLC treatment.
Luke Pike, MD, shares key takeaways from the TURBO-Non–Small Cell Lung Cancer study and highlights promising studies on the horizon for EGFR mutant NSCLC treatment.
Luke Pike, MD, shares key...
09/18/2024
Journal of Clinical Pathways
Jamie Chaft, MD, Memorial Sloan Kettering Cancer Center
Videos
Updated 5-Year Data From the IMpower010 Trial
09/17/2024
Jamie Chaft, MD, discusses the 5-year follow-up data from the IMpower010 trial which showed atezolizumab continued to provide greater improvement to disease-free survival than best supportive care for patients with resectable early-stage...
Jamie Chaft, MD, discusses the 5-year follow-up data from the IMpower010 trial which showed atezolizumab continued to provide greater improvement to disease-free survival than best supportive care for patients with resectable early-stage...
Jamie Chaft, MD, discusses the...
09/17/2024
Oncology
Luke Pike, MD
Videos
Evaluating Stereotactic Radio Surgery Plus TKI Vs TKI Alone Among Patients With Brain Metastases from EGFR- and ALK-Altered NSCLC (Part I)
09/05/2024
Luke Pike, MD, breaks down the TURBO-Non–Small Cell Lung Cancer study and summarizes the main findings.
Luke Pike, MD, breaks down the TURBO-Non–Small Cell Lung Cancer study and summarizes the main findings.
Luke Pike, MD, breaks down the...
09/05/2024
Journal of Clinical Pathways
Sawsan Rashdan, MD
Videos
Safety and Efficacy of Osimertinib Plus Consolidative Stereotactic Ablative Radiation in Patients With Advanced EGFR Mutant NSCLC
08/28/2024
Sawsan Rashdan, MD, shares the main findings from her study on the use of osimertinib plus consolidative stereotactic ablative radiation for treating patients with advanced EGFR-mutated non–small cell lung cancer (NSCLC).
Sawsan Rashdan, MD, shares the main findings from her study on the use of osimertinib plus consolidative stereotactic ablative radiation for treating patients with advanced EGFR-mutated non–small cell lung cancer (NSCLC).
Sawsan Rashdan, MD, shares the...
08/28/2024
Journal of Clinical Pathways
Ticiana Leal, MD
Videos
ALK Testing Patterns for Patients With Early-Stage Non–Small Cell Lung Cancer
08/21/2024
Ticiana Leal, MD, shares results from her study on anaplastic lymphoma kinase (ALK) testing patterns in patients with early-stage non–small cell lung cancer (NSCLC).
Ticiana Leal, MD, shares results from her study on anaplastic lymphoma kinase (ALK) testing patterns in patients with early-stage non–small cell lung cancer (NSCLC).
Ticiana Leal, MD, shares results...
08/21/2024
Journal of Clinical Pathways
Videos
Best Management Practices for a Patient With Early-Stage Non-Small Cell Lung Cancer
08/02/2024
Ticiana Leal, MD, discusses the course of treatment she would take for a patient with early-stage NSCLC.
Ticiana Leal, MD, discusses the course of treatment she would take for a patient with early-stage NSCLC.
Ticiana Leal, MD, discusses the...
08/02/2024
Oncology
JCP September/October 2024 Issue

Current Issue

October 2024
Volume 10
Issue 5
Current Issue
Issue Archive

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use